Laboratory Tests
Current cardiac biomarker tests used to help diagnose, evaluate, and monitor patients suspected of having Acute Coronary Syndrome (ACS):
Additional biomarker tests that may be used to evaluate risk of future cardiac events (prognosis):
Phased out biomarkers—the tests below are not specific for damage to the heart and are no longer recommended for evaluating patients with suspected ACS:
More general tests frequently ordered along with cardiac biomarkers:
On the horizon:
- Ischemia modified albumin (IMA) – This test has received FDA approval for use with troponin and an electrocardiogram. It is not widely available but may become useful someday for identifying patients at higher risk of heart attack.
Non-laboratory Tests
These tests allow doctors to look at the size, shape, and function of the heart as it is beating. They can be used to detect changes to the rhythm of the heart as well as to detect and evaluate damaged tissues and blocked arteries.
